← back to search

Stephen Tukwasibwe

University of London ·
Area of research
Public Health, Environmental and Occupational Health · Parasitology
Research interest
Research focused on Plasmodium falciparum and Malaria, with related work in Drug resistance, Eclampsia, Pregnancy. Notable publications include 'A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia', 'Changing antimalarial drug resistance patterns identified by surveillance at three sites in Uganda', and 'Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population'.
h-index
citations
464
works
10
NIH funding
primary concept
email

Recent publications

Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health
Scientific Reports 2025cited by 31position: middledoi
Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial
The Lancet Infectious Diseases 2025cited by 9position: middledoi
Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria
Science Translational Medicine 2023cited by 48position: middledoi
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance–Mediating Polymorphisms in Uganda
The Journal of Infectious Diseases 2017cited by 30position: middledoi
Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda
Infection Genetics and Evolution 2017cited by 28position: middledoi
Changing antimalarial drug resistance patterns identified by surveillance at three sites in Uganda
The Journal of Infectious Diseases 2016cited by 63position: middledoi
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity
Antimicrobial Agents and Chemotherapy 2016cited by 34position: middledoi
A <i>KIR B</i> centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia
Proceedings of the National Academy of Sciences 2015cited by 149position: middledoi
Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda
The Journal of Infectious Diseases 2014cited by 22position: firstdoi
Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population
Immunogenetics 2013cited by 50position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Philip J. Rosenthal · University of California, San Francisco6 papers (2014–2025)Samuel L. Nsobya · University of London5 papers (2014–2025)Moses R. Kamya · Universidad Católica de Santa Fe5 papers (2016–2025)Melissa D. Conrad · University of North Carolina at Chapel Hill4 papers (2016–2025)Grant Dorsey · Universidad Católica de Santa Fe4 papers (2016–2017)Joaniter I. Nankabirwa · Liverpool School of Tropical Medicine3 papers (2016–2025) · 3 papers (2016–2017) · 2 papers (2013–2015) · 2 papers (2013–2015)Pontiano Kaleebu · Uganda Virus Research Institute2 papers (2013–2015)Victor Asua · Infectious Diseases Research Collaboration2 papers (2016–2025) · 2 papers (2017–2025)Jennifer Legac · University of California, San Francisco2 papers (2016–2017)Lydia Farrell · Swansea University2 papers (2013–2015)Sarah G. Staedke · Liverpool School of Tropical Medicine2 papers (2016–2016) · 2 papers (2013–2015) · 2 papers (2016–2025) · 2 papers (2013–2015) · 2 papers (2013–2015)Alison M. Elliott · Uganda Virus Research Institute2 papers (2013–2015)